Tagged with P

BPOM How has the increasing international integration of the Indonesian economy influenced the challenges and transformations the BPOM went through in the past 9 years since its reorganization? The constant changes and upgrades in international standards in the last decade posed strategic choices to our agency. Since then, BPOM chose to…

APL APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being a part of Zuellig provides a significant competitive advantage for APL. The international nature of the company has necessitated processes, procedures, ethical transparency and…

Millennium Pharmacon International Millennium Pharmacon International has a long history, starting at its founding in 1952. Could you give our readers an overview of the company’s milestones, particularly those from the past decade? Millennium Pharmacon International, or MPI as is more known, used to be named PT NVPD Soedarpo Corporation Tbk. This is…

Pfizer South Korea Previous to your current position as President of Pfizer Korea since 2004, you had been in the country between 1989 and 1993 as sales and marketing director. How different are things in Korea’s pharmaceutical industry 15 years since you first left it? South Korea has evolved dramatically over the last…

Solvay Pharma Indonesia While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on the Asia Pacific region, which for the Pharmaceutical segment represents still less than 9% of the sales. In this respects,…

Korea National Enterprise for Clinical Trials Korea had a late start, but is now one of the global hot spots for clinical trials. How would you sum up and explain this quick evolution? Clinical trials in Korea began in the 1990s, but at that time they were limited to either local studies for domestically developed compounds…

Anugerah Corporation The development of the Local Pharmaceutical industry companies has gone through rough times, competing from the very beginning with MNCs and going through the economic shock in the 90’s. In this period while many companies couldn’t cope with the market competition, Anguerah Corporation succeeded in positioning itself as one of…

Parexel International Italy Over more than 25 years, PAREXEL has expanded its global footprint through a combination of organic growth, alliances, and acquisitions. What was the rationale behind entering Italy in 1995 and which opportunities does the local environment provide to the group? The high number of clinical trials conducted in Italy every…

GPFarmasi Local firms have assumed an increasing role in the Indonesian pharmaceutical market representing today more than 75% of the market share and being able to provide over 90% of the medicines required by the population. What have been the main drivers of this change? The Indonesian pharmaceutical industry started in…

Neurotech Pharmaceuticals What was the vision behind the creation of Neurotech back in 1998, originally as a Research Center, and then as an independent bio-tech company? It all began in 1998 when special new laws were passed by the Korean government aiming to get professors to contribute to the development of the…

Eurogroup Consulting Italy Dr Fazi, you co-founded Eurogroup Consulting (EGC) in Italy in 2007 and are now leading a well established reality, renowned for the new model of governance it has designed. Could you introduce to our readers the main guidelines and principles of this innovative approach to consulting? M.F: The Italian consulting…

SOHO Group For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been the key characteristics that made the company stand out from the competition? The factors enabling us to achieve those results…